An Antibody-armored Dendritic Cell in Patients With Solid Tumors

Clinical trial NCT07479667 · RECRUITING

Trial details

NCT number: NCT07479667
Sponsor: Shanghai Cell Therapy Group Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Cancers Adjuvant Therapy

Start date: 2026-02-05
Primary completion: 2028-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.